Comprehensive profiling of A?40 and A?42 fibril-interacting proteins reveals PRKCG as a drug-targetable regulator of amyloidogenesis in Alzheimer's disease - Montero-Calle A; Coronel R; Manosalva J; Megías D; de los Ríos V; Rábano A; Peláez-García A; Martínez-Useros J; Fernández-Aceñero MJ; Liste I; Barderas R (Alzheimers & Dementia, 2026)